American Oncology Network Stock Price Prediction
| AONC Stock | 11.12 0.88 7.33% |
Momentum 52
Impartial
Oversold | Overbought |
Quarterly Revenue Growth 0.514 |
Using American Oncology hype-based prediction, you can estimate the value of American Oncology Network from the perspective of American Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in American Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying American because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
American Oncology after-hype prediction price | USD 12.99 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out American Oncology Basic Forecasting Models to cross-verify your projections. American Oncology After-Hype Price Prediction Density Analysis
As far as predicting the price of American Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in American Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of American Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
American Oncology Estimiated After-Hype Price Volatility
In the context of predicting American Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on American Oncology's historical news coverage. American Oncology's after-hype downside and upside margins for the prediction period are 0.65 and 28.56, respectively. We have considered American Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
American Oncology is very risky at this time. Analysis and calculation of next after-hype price of American Oncology Network is based on 3 months time horizon.
American Oncology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as American Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading American Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with American Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.42 | 15.57 | 0.99 | 0.00 | 5 Events / Month | 0 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
11.12 | 12.99 | 8.25 |
|
American Oncology Hype Timeline
American Oncology Network is presently traded for 11.12. The entity has historical hype elasticity of 0.99, and average elasticity to hype of competition of 0.0. American is estimated to increase in value after the next headline, with the price projected to jump to 12.99 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 8.25%, whereas the daily expected return is presently at 1.42%. The volatility of related hype on American Oncology is about 0.0%, with the expected price after the next announcement by competition of 11.12. The company has return on total asset (ROA) of (0.0238) % which means that it has lost $0.0238 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3017) %, meaning that it created substantial loss on money invested by shareholders. American Oncology's management efficiency ratios could be used to measure how well American Oncology manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.0083. The current year's Return On Capital Employed is expected to grow to -0.07. At present, American Oncology's Intangibles To Total Assets are projected to increase slightly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 21.23, whereas Total Assets are forecasted to decline to about 312.3 M. Given the investment horizon of 90 days the next estimated press release will be in about 5 days. Check out American Oncology Basic Forecasting Models to cross-verify your projections.American Oncology Related Hype Analysis
Having access to credible news sources related to American Oncology's direct competition is more important than ever and may enhance your ability to predict American Oncology's future price movements. Getting to know how American Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how American Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ORPEF | Orpea SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EVGRF | China Evergrande New | 0.00 | 2 per month | 0.00 | 0.05 | 0.00 | 0.00 | 39.68 | |
| TRGNF | Transgene SA | 0.00 | 0 per month | 0.00 | 0.09 | 0.00 | 0.00 | 61.69 | |
| DMTRF | 3 D Matrix | 0.00 | 0 per month | 0.00 | 0.16 | 0.00 | 0.00 | 27.33 | |
| MAYNF | Mayne Pharma Group | 0.00 | 0 per month | 0.00 | (0.02) | 10.59 | (9.09) | 46.83 | |
| HNSBF | Hansa Biopharma AB | 0.00 | 0 per month | 0.00 | 0.02 | 0.00 | 0.00 | 89.13 | |
| SLNCF | Silence Therapeutics plc | 0.00 | 0 per month | 0.00 | 0.11 | 12.50 | (6.25) | 45.00 | |
| MKLNF | M1 Kliniken AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BHCCF | Benchmark Holdings plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MFCSF | Medical Facilities | 0.00 | 0 per month | 1.35 | 0.01 | 2.98 | (2.24) | 7.83 |
American Oncology Additional Predictive Modules
Most predictive techniques to examine American price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for American using various technical indicators. When you analyze American charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About American Oncology Predictive Indicators
The successful prediction of American Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as American Oncology Network, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of American Oncology based on analysis of American Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to American Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to American Oncology's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 9.9 | 9.37 | 9.62 | 7.64 | Days Of Inventory On Hand | 12.63 | 13.6 | 13.5 | 14.93 |
Story Coverage note for American Oncology
The number of cover stories for American Oncology depends on current market conditions and American Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that American Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about American Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
American Oncology Short Properties
American Oncology's future price predictability will typically decrease when American Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of American Oncology Network often depends not only on the future outlook of the potential American Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. American Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13.5 M | |
| Cash And Short Term Investments | 72.6 M |
Complementary Tools for American Stock analysis
When running American Oncology's price analysis, check to measure American Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy American Oncology is operating at the current time. Most of American Oncology's value examination focuses on studying past and present price action to predict the probability of American Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move American Oncology's price. Additionally, you may evaluate how the addition of American Oncology to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |